Back

Clinical benefits of concurrent treatment of dyslipidemia and hypertension.

19 April 2018 (13:05 - 13:20)
Organised by:
Congress Presentation Part of: The power of synergy. Cardiovascular Pharmacotherapy EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Professor Borut Jug

University Medical Centre of Ljubljana, Ljubljana (Slovenia)

4 More presentations in this session

Presentation thumbnail
Introduction - The power of synergy.
Professor Z. Fras (Ljubljana, SI)
Slides Video
Presentation thumbnail
Challenges of concurrent treatment of dyslipidemia and hypertension.
Professor I. Graham (Dublin, IE)
Slides Video
Presentation thumbnail
From science to practice: a patient case.
Professor M. Banach (Lodz, PL)
Slides Video
Presentation thumbnail
Conclusion - The power of synergy.
Professor Z. Fras (Ljubljana, SI)
Slides Video

Access the full session

Session thumbnail
The power of synergy.

The Event

Event poster

EuroPrevent 2018

19 April 2018 13:05 CET
You may be interested in
thumbnail
Congress Presentation
Multimorbid patient management: are we meeting the needs of patients with hypertension and dyslipidaemia?
1 September 2024
thumbnail
Congress Presentation
Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with valsartan/amlodipine in prediabetic patients
7 April 2022
thumbnail
Congress Presentation
Residual cardiovascular risk of patients with dyslipidemia receiving multifactorial cardiovascular prevention therapy
27 August 2021
thumbnail
Webinar
ESC Webinar : New 2018 Arterial Hypertension guidelines: which cut-off for which patient?
26 September 2018

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources